Neoimmunetech
Clinical trials sponsored by Neoimmunetech, explained in plain language.
-
New drug aims to boost Cancer-Fighting CAR-T cells
Disease control CompletedThis study tested a drug called NT-I7 in patients with aggressive lymphoma that returned after CAR-T therapy. The main goal was to find a safe dose and see if NT-I7 could help the CAR-T cells last longer and fight the cancer better. The trial involved 17 adults who had already re…
Phase: PHASE1 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New Two-Drug attack tested against Tough-to-Treat cancers
Disease control CompletedThis study tested a new combination of two drugs, NT-I7 and pembrolizumab, for people with advanced solid tumors that had returned or stopped responding to prior therapies. The main goals were to find a safe dose and see if the combination could shrink tumors in several hard-to-t…
Phase: PHASE1, PHASE2 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC